Stock Track | Axon Enterprise Soars 6.68% Pre-market on Strong Q1 Results, Raised Outlook, and Analyst Upgrades

Stock Track
08 May

Axon Enterprise, Inc. (NASDAQ: AXON) stock is surging 6.68% in pre-market trading, building on its 5.68% gain from the previous session. The continued upward momentum comes after the company reported impressive first-quarter 2025 financial results, raised its full-year guidance, and received multiple analyst price target increases.

Axon, known for its TASER devices and law enforcement technology products, reported Q1 2025 adjusted earnings of $1.41 per share, significantly beating the analyst consensus estimate of $1.27. Revenue for the quarter reached $603.6 million, up 31% year-over-year and exceeding analyst estimates of $583.8 million. The company's Software & Services segment showed particularly strong growth, with revenue increasing 39% to $263 million.

Following the strong results, Axon raised its full-year 2025 revenue guidance to a range of $2.60 billion to $2.70 billion, up from the previous forecast of $2.55 billion to $2.65 billion. The company also increased its Adjusted EBITDA outlook to between $650 million and $675 million. In response to the positive developments, several analysts have raised their price targets for Axon stock. JP Morgan increased its target to $730 from $665, Morgan Stanley raised its target to $695 from $635, Needham boosted its target to $750 from $600, and TD Cowen lifted its target to $750 from $725. The combination of strong financial performance and positive analyst sentiment appears to be driving investor enthusiasm for Axon shares in the pre-market session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10